IP Library Granted Patent US 8,715,987
Granted Patent B2
US 8,715,987 · App. 13/450,549 · Granted May 6, 2014

Solubilized phospholipids for stabilizing nucleic acid polymerases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,715,987
App. No.
13/450,549
Granted
May 6, 2014
Kind
B2
Abstract

Compositions and methods are provided that relate to solubilized phospholipids and their use in stabilizing nucleic acid polymerases. For example, a phospholipid with a tail containing at least 8 carbons can be solubilized in the presence of an amphipathic molecule.

Claims (11)

1. A composition comprising: a thermostable polymerase in a buffer comprising a solubilized long-chain phospholipid, wherein the phospholipid has at least one hydrophobic tail containing 8 to 30 carbons.

2. A composition according to claim 1 , further comprising an amphipathic solubilizer.

3. A composition according to claim 2 , wherein the amphipathic molecule is a lipid having a hydrophobic tail containing no more than 8 carbons.

4. A composition according to claim 1 , wherein the at least one long-chain phospholipid is a phosphatidylcholine.

5. A composition according to claim 1 , wherein the activity of the polymerase is enhanced in the presence of the solubilized phospholipid, capable of being measured in a replication assay by incorporation of deoxynucleoside triphosphate.

6. A composition according to claim 5 , wherein the enhancement is at least 3-fold.

7. A kit, comprising:

a thermostable polymerase in a buffer containing a solubilized phospholipid having 8 to 30 carbons and a stabilizer.

8. A kit according to claim 7 , wherein the stabilizer is a lipid having a hydrophobic tail containing no more than 8 carbons.

9. The composition of claim 1 , wherein said thermostable polymerase is a Taq polymerase.

10. The composition of claim 1 , wherein the phospholipid has at least one hydrophobic tail containing 8 to 20 carbons.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2012
From: JOHNSON, DONALD; EVANS, THOMAS C.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 028072/0630 →